Michel L. tremblay and Martin J. Blaser were awarded the title of Doctor Honoris Causa by Dean Lewis, president of the University of Bordeaux after their praises by Andréas Bikfalvi (team 1) and Philippe Lehours (team 4) respectively. Honoris Causa The title of Doctor Honoris...
In the context of the awarding of the title Honoris Causa to Michel L. Tremblay (Goodman Cancer Institute, McGill University, Montreal, Quebec, Canada) by the University of Bordeaux (May 10 at 5:00 pm), Andreas Bikfalvi and the researchers of the unit are organizing a...
Read the article written by Candice Ménégon for the SBM Department on the recent publication of Team 10 - Normal and Leukemic Hematopoietic Stem Cells, directed by Jean-Max Pasquet. Targeting autophagy and hematologic mobilization in FLT3-ITD acute myeloid leukemia (1/3 of patients) decreases repopulation capacity...
Visit of our future premises by a delegation of our unit. The new "Research Building" is under construction by the University of Bordeaux on the Carreire site. It will house 7 of our 11 teams.
Congratulations! At the Annual Scientific Symposium of the Fondation Maladies Rares, the Alnylam was given to Christine Labreze and François Moisan (Team 05 - Translational research in cutaneous oncology and rare skin diseases - TRIO2), for their project "Interfering RNA approach targeting the mutation of...
